New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
DarioHealth Corp.
DRIO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

30M

Medical - Diagnostics & Research

Next Earning date - 07 Nov 2024

30M

Medical - Diagnostics & Research

Next Earning date - 07 Nov 2024

1.00USD
Shape-0.03 ( -2.94%)
Market Open
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-96%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated October 18, 2024
1W -6.13 % 1M -2.37 % 3M -18.65 % 1Y -64.24 %

Key Metrics

Shape
  • Market Cap

    30.03M


  • Shares Outstanding

    30.03M


  • Share in Float

    24.67M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    1


  • Average Volume

    93909


  • Beta

    1.483


  • Range

    0.68-2.77


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.mydario.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.57x

P/S Ratio

0.59x

P/B Ratio

0.4

Debt/Equity

-28.1%

Net Margin

$-1.2

EPS

How DRIO compares to sector?

P/E Ratio

Relative Strength

Shape

DRIO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$37M

Shape491%

2025-Revenue

$0.80

Shape-842%

2025-EPS

$37M

Shape-160%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Alliance Global Partners

upgrade

Previous: Not converted

2022-05-13

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.64
vs -1.18

Q4.22

arrow
arrow

N/A

-0.51
vs -1.09

Q1.23

arrow
arrow

+161%

0.45
vs -0.74

Q2.23

arrow
arrow

N/A

-0.58
vs -0.74

Q3.23

arrow
arrow

N/A

-0.49
vs -0.64

Q4.23

arrow
arrow

N/A

-0.51
vs -0.51

Q1.24

arrow
arrow

N/A

-0.20
vs 0.45

Q2.24

arrow
arrow

+110%

0.06
vs -0.58

Q3.24

arrow
arrow

N/A

-0.22
vs -0.49

Q4.24

arrow
arrow

N/A

-0.19
vs -0.51

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+17%

6.6M  vs 5.6M

Q4.22

arrow
arrow

+13%

6.8M  vs 6M

Q1.23

arrow
arrow

-12%

7.1M  vs 8.1M

Q2.23

arrow
arrow

0%

6.2M  vs 6.2M

Q3.23

arrow
arrow

-47%

3.5M  vs 6.6M

Q4.23

arrow
arrow

-47%

3.6M  vs 6.8M

Q1.24

arrow
arrow

-19%

5.8M  vs 7.1M

Q2.24

arrow
arrow

+2%

6.3M  vs 6.2M

Q3.24

arrow
arrow

+110%

7.4M  vs 3.5M

Q4.24

arrow
arrow

+117%

7.8M  vs 3.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-19%

-0.19
vs -0.18

Q4.22

arrow
arrow

-16%

-0.16
vs -0.19

Q1.23

arrow
arrow

+17%

0.17
vs -0.16

Q2.23

arrow
arrow

-21%

-0.21
vs 0.17

Q3.23

arrow
arrow

+25%

0.25
vs -0.21

Q4.23

arrow
arrow

-21%

-0.21
vs 0.25

Q1.24

arrow
arrow

-9%

-0.09
vs -0.21

Q2.24

arrow
arrow

-5%

-0.05
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

48

48
vs 60

-20%

Q4.22

arrow
arrow

51

51
vs 48

6%

Q1.23

arrow
arrow

47

47
vs 51

-8%

Q2.23

arrow
arrow

48

48
vs 47

2%

Q3.23

arrow
arrow

43

43
vs 48

-10%

Q4.23

arrow
arrow

38

38
vs 43

-12%

Q1.24

arrow
arrow

38

38
vs 38

NA

Q2.24

arrow
arrow

41

41
vs 38

8%

Earnings Growth

Latest News